BriaCell Therapeutics Corp. Warrant

BCTXZNASDAQHealthcare● Active

$0.08

+$0.00(+0.75%)

Market Cap$150888

P/E Ratio—

52W High$0.0863

52W Low$0.065

Avg Volume29K

Open$0.08

Beta1.64

Earnings Financials Revenue

BriaCell Therapeutics Corp. Warrant (BCTXZ) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

BCTXZ · earnings · updated Jun 9, 2026

No earnings history available.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

No earnings history available.

Analyst Estimates

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q4 FY2025	$0.00	$0.00	$0.00	0

Revenue Estimates

Period	Low	Consensus	High	# Analysts
Q4 FY2025	$0.0B	$0.0B	$0.0B	1

About Earnings & Data Methodology

BriaCell Therapeutics Corp. Warrant (BCTXZ) reports earnings quarterly as a NASDAQ-listed Biotechnology company. The next BCTXZ earnings date is expected around September 1, 2026.

Each quarter, investors track BCTXZ earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BCTXZ revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

BCTXZ's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

BCTXZ earnings · 3 questions

BriaCell Therapeutics Corp. Warrant's next earnings report is expected around September 1, 2026. BCTXZ typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BCTXZ historically reports after market close (AMC).

BCTXZ earnings datewhen is BCTXZ earningsBCTXZ next earnings datewhen does BCTXZ report earningsBCTXZ earnings calendar

▸ Source: FMP · BriaCell Therapeutics Corp. Warrant SEC filings · US GAAP · BriaCell Therapeutics Corp. Warrant SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026